President Donald Trump signed an executive order this month to reduce the number of recommended federal childhood immunizations and instructed the Justice Department to challenge state-level vaccine mandates for schools. According to current and former administration officials, the directive followed the president’s internal pressure on Health Secretary Robert F. Kennedy Jr. to produce research linking vaccines to autism, a connection that medical experts state has been disproven by extensive research.
The executive order mandates a reduction in the federal childhood vaccine schedule from 17 shots to 11. It also directs the Department of Health and Human Services (HHS) to unbundle the measles, mumps, and rubella (MMR) vaccine into three separate doses. Administration officials noted the order was developed quickly following a July 31 cabinet meeting where the president questioned Kennedy on the progress of his autism research.
Kennedy, who assumed office in early 2025, previously attempted to implement a similar reduced schedule in January. However, a federal judge issued an injunction against those changes in March, ruling that health regulators had acted unlawfully. The administration is currently appealing that decision. HHS spokeswoman Grace Davis Jamison confirmed the department is currently conducting dozens of studies using federal health datasets to investigate chronic disease and vaccine safety.
Medical associations and public health advocates have stated that the order may lead to increased vaccine hesitancy, potentially exposing more children to preventable illnesses. If the Justice Department successfully challenges state-level mandates, the legal requirements for school attendance could shift across the country, affecting students and school administrators. The cost of administering 11 separate shots versus combined doses may also impact healthcare billing and insurance coverage, though specific per-household dollar amounts were not reported.
The directive sets a precedent for executive intervention in vaccine schedules, which are typically managed through standard agency regulatory procedures. The next steps involve the administration's appeal of the March injunction and the results of ongoing HHS studies. Kennedy had previously set deadlines for autism research findings in September 2025 and March 2026, both of which passed without new data. Officials indicate that the current research projects, which include looking at the effects of thimerosal and immune system alterations, could take several more months to complete.